2019 American Transplant Congress
Incidence and Risks for Non-alcoholic Fatty Liver Disease and Steatohepatitis Post Liver Transplant: Systematic Reveiw and Meta-Analysis
1Beaumont Hospital, Ann Arbor, MI, 2University of Michigan, Ann Arbor, MI
*Purpose: Recurrent and denovo non-alcoholic fatty liver (NAFLD) and non-alcoholic steatohepatitis (NASH) are important post-liver transplant (LT) outcomes given risk to graft viability. The true…2019 American Transplant Congress
Multidisciplinary Practitioner Perspectives on Cardiovascular Disease Guideline Interventions in Liver Transplant Recipients
*Purpose: Cardiovascular disease (CVD) is a leading cause of mortality in liver transplant recipients (LTRs). However, there is a lack of LT-specific CVD clinical practice…2019 American Transplant Congress
Hypoadiponectinemia is Associated with Low Handgrip Strength in Renal Transplant Recipients
*Purpose: Adiponectin was synthesized and expressed by adipocytes. However, recently it was suggested that adiponectin is also secreted and expressed by skeletal muscle. Decline of…2019 American Transplant Congress
BMI Changes and Its Impact on Long Term Follow-Up in Kidney Transplant Recipients
Dept. of Nephrology, Jagiellonian University Medical College, Krakow, Poland
*Purpose: BMI has an effect on patients with chronic kidney disease (CKD) and after kidney transplantation (ktx). Higher body weight and use of immunosuppressive treatment…2019 American Transplant Congress
Normal Coronary Angiogram Pre-Transplant Does Not Predict Cardiac Events in Diabetic Kidney Transplant Recipients
University of Wisconsin, Madison, WI
*Purpose: Cardiac events (CE) are a common cause of death in kidney transplant recipients. The aim of this study was to determine the risk factors…2019 American Transplant Congress
Serum Apolipoproteins B and A1 Predict the Development of Late Post-Transplant Diabetes Mellitus in Prevalent Adult Kidney Transplant Recipients
St Michael's Hospital, University of Toronto, Toronto, ON, Canada
*Purpose: Post-transplant diabetes mellitus (PTDM) increases adverse outcomes. The risk factors for PTDM have not been fully delineated. Glucose metabolism links closely to cholesterol metabolism.…2019 American Transplant Congress
Efficacy And Safety Of Febuxostat In Renal Transplant Recipients With Hyperuricemia
*Purpose: To assess the efficacy and safety of febuxostat in the treatment of hyperuricemia in renal transplant recipients.*Methods: A total number of 124 renal transplant…2019 American Transplant Congress
Serum Adipocyte Fatty Acid Binding Protein Level is Negatively Associated with Vascular Reactivity Index Measured by Digital Thermal Monitoring in Kidney Transplant Patients
*Purpose: Adipocyte fatty acid-binding protein (A-FABP) is abundantly found in mature adipocytes, activated macrophages, and dendritic cells and is involved in lipid metabolism, metabolic and…2019 American Transplant Congress
The Comparison of Glycemic Profiles during Post-Operative Early Period between Liver and Kidney Transplantation Assessed by Continuous Glucose Monitoring System
*Purpose: Newly developed hyperglycemia and worsening of previously well controlled glucose control are common after transplantation because of stressful condition and immunosuppressive agents including of…2019 American Transplant Congress
New-Onset Diabetes after Kidney Transplantation: Risk Factors and Early Graft Function Outcome
Kidney Disease Center, First Affiliated Hospital of Zhejiang University, Hangzhou, China
*Purpose: New-onset of diabetes mellitus after transplantation (NODAT) is a serious and common complication following solid organ transplantation. Our study aims to examine the risk…
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 8
- Next Page »